Lymphohematopoietic factors and biological control mechanisms.
Farrar
W L
WL
Laboratory of Molecular Immunoregulation, National Cancer Institute, Frederick Cancer Research Facility, MD 21701-1013.
Linnekin
D
D
D000818:Animals; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D003115:Colony-Stimulating Factors / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000494:pharmacology*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology*; D007377:Interleukin-3 / Q000494:pharmacology*; D007951:Leukemia, Myeloid / Q000473:pathology; D051379:Mice; D010750:Phosphoproteins / Q000378:metabolism*; D011494:Protein Kinases / Q000502:physiology*; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D011505:Protein-Tyrosine Kinases / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D007376:Interleukin-2; D007377:Interleukin-3; D010750:Phosphoproteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D011494:Protein Kinases; D011505:Protein-Tyrosine Kinases; D017871:Calcium-Calmodulin-Dependent Protein Kinases